Brazil Pharmacovigilance Market Forecast by 2033

Market Size in 2024: USD 157.25 Million
Market Forecast in 2033: USD 282.92 Million
Market Growth Rate 2025-2033: 6.24%

The Brazil pharmacovigilance market is poised for significant growth, driven by regulatory mandates, technological advancements, and the increasing demand for robust drug safety monitoring. The market size in 2024 was USD 157.25 million, with a forecasted value of USD 282.92 million by 2033, exhibiting a compound annual growth rate (CAGR) of 6.24% during the period from 2025 to 2033.

Brazil Pharmacovigilance Market Growth Drivers

Increased Regulatory Scrutiny and Compliance

The Brazilian pharmacovigilance market is experiencing a surge in regulatory oversight, with authorities placing a heightened emphasis on drug safety and patient welfare. The National Health Surveillance Agency (ANVISA) has implemented stringent measures to monitor adverse drug reactions (ADRs) and ensure compliance with international standards. For instance, in March 2024, ANVISA approved Normative Ruling No. 289/2024 to streamline the registration process for medicines, vaccines, and APIs, thereby improving market access. This regulation underscores the need for pharmaceutical companies to enhance their pharmacovigilance systems and reporting procedures. The adoption of data analysis and digital tools is crucial for meeting these regulatory requirements accurately and efficiently. As Brazil aligns with global pharmacovigilance standards, the demand for advanced pharmacovigilance solutions continues to rise, driving market expansion.

Rapid Adoption of Advanced Technologies

The increasing utilisation of advanced technologies is a key trend in the Brazilian pharmacovigilance market. Companies are leveraging artificial intelligence (AI), machine learning (ML), and big data analytics to enhance real-time identification, evaluation, and reporting of adverse drug reactions. For example, in December 2024, the Brazilian Senate approved Bill No. 2,338/2023 to regulate AI development, usage, and governance, emphasising responsible innovation and safety. These technologies enable faster processing of large datasets, improving the precision and efficiency of pharmacovigilance tasks. Automated reporting systems and AI-powered safety monitoring assist pharmaceutical companies in proactively identifying safety concerns, minimising manual errors, and maintaining regulatory compliance. Continuous technological advancements are transforming pharmacovigilance procedures in Brazil, leading to improved drug safety monitoring and risk reduction within the sector.

Expansion of Outsourced Pharmacovigilance Services

The growth of outsourced pharmacovigilance services in Brazil is driven by the increasing complexity of regulatory requirements and the need for specialized expertise. Smaller and mid-sized pharmaceutical companies are increasingly turning to third-party providers for assistance with drug safety monitoring and reporting duties. Outsourcing allows these companies to access advanced technology and data analytics tools, enhancing their pharmacovigilance processes. For instance, Brazil's IT outsourcing market is expanding, supported by a skilled workforce, competitive pricing, and a growing technology ecosystem. The International Data Corporation (IDC) forecasts an annual growth rate of 5.95%, reaching $8.09 billion by 2028. Outsourcing enables companies to focus on their core business operations while ensuring compliance with evolving regulatory standards, particularly those set by ANVISA. The demand for outsourced pharmacovigilance services is expected to continue growing as companies seek to optimize their operations and manage regulatory complexities.

Request a Sample Report to Gain Deeper Insights:https://www.imarcgroup.com/brazil-pharmacovigilance-market/requestsample

Brazil Pharmacovigilance Market Segmentation

Analysis by Service Provider

• In-House
• Contract Outsourcing

Analysis by Product Life Cycle

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Analysis by Type

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Analysis by Process Flow

• Case Data Management
  • Case Logging
  • Case Data Analysis
  • Medical Reviewing and Reporting
• Signal Detection
  • Adverse Event Logging
  • Adverse Event Analysis
  • Adverse Event Review and Reporting
• Risk Management System
  • Risk Evaluation System
  • Risk Mitigation System

Analysis by Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Respiratory System
• Others

Analysis by End Use

• Pharmaceutical Companies
• Bio Technology Companies
• Medical Device Companies
• Others

Analysis by Region

• Southeast
• South
• Northeast
• North
• Central-West

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Brazil Pharmacovigilance Market News

• In March 2024, ANVISA approved Normative Ruling No. 289/2024 to streamline the registration process for medicines, vaccines, and APIs, enhancing market access.
• In December 2024, the Brazilian Senate approved Bill No. 2,338/2023 to regulate AI development, usage, and governance, emphasizing responsible innovation and safety.
• The International Data Corporation (IDC) forecasts an annual growth rate of 5.95% for Brazil's IT outsourcing market, reaching $8.09 billion by 2028.
• The market is increasingly adopting advanced technologies such as AI and big data analytics to improve pharmacovigilance processes and regulatory compliance.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.